1. Home
  2. MIND vs MGNX Comparison

MIND vs MGNX Comparison

Compare MIND & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIND
  • MGNX
  • Stock Information
  • Founded
  • MIND 1987
  • MGNX 2000
  • Country
  • MIND United States
  • MGNX United States
  • Employees
  • MIND N/A
  • MGNX N/A
  • Industry
  • MIND Industrial Machinery/Components
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIND Industrials
  • MGNX Health Care
  • Exchange
  • MIND Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • MIND 85.5M
  • MGNX 99.7M
  • IPO Year
  • MIND 1994
  • MGNX 2013
  • Fundamental
  • Price
  • MIND $8.24
  • MGNX $1.69
  • Analyst Decision
  • MIND
  • MGNX Hold
  • Analyst Count
  • MIND 0
  • MGNX 6
  • Target Price
  • MIND N/A
  • MGNX $3.20
  • AVG Volume (30 Days)
  • MIND 214.1K
  • MGNX 1.0M
  • Earning Date
  • MIND 09-09-2025
  • MGNX 11-04-2025
  • Dividend Yield
  • MIND N/A
  • MGNX N/A
  • EPS Growth
  • MIND N/A
  • MGNX N/A
  • EPS
  • MIND 2.54
  • MGNX N/A
  • Revenue
  • MIND $48,612,000.00
  • MGNX $165,495,000.00
  • Revenue This Year
  • MIND $7.27
  • MGNX N/A
  • Revenue Next Year
  • MIND N/A
  • MGNX N/A
  • P/E Ratio
  • MIND $3.32
  • MGNX N/A
  • Revenue Growth
  • MIND 27.70
  • MGNX 303.47
  • 52 Week Low
  • MIND $3.47
  • MGNX $0.99
  • 52 Week High
  • MIND $11.50
  • MGNX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • MIND 40.68
  • MGNX 51.53
  • Support Level
  • MIND $8.03
  • MGNX $1.46
  • Resistance Level
  • MIND $8.73
  • MGNX $1.77
  • Average True Range (ATR)
  • MIND 0.59
  • MGNX 0.15
  • MACD
  • MIND -0.20
  • MGNX -0.03
  • Stochastic Oscillator
  • MIND 8.40
  • MGNX 29.61

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: